References
- Degertekin M, Serruys PW, Foley DP et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 106, 1610–1613 (2002).
- Woods TC, Marks AR. Drug-eluting stents. Annu. Rev. Med. 55, 169–178 (2004).
- Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56, 139–145 (1985).
- Hagensen MK, Raarup MK, Mortensen MB et al. Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc. Res. 93, 223–231 (2012).
- Finn AV, Joner M, Nakazawa G et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115, 2435–2441 (2007).
- Tang R, Cui X-B, Wang J-N, Chen S-Y. CTP synthase 1, a smooth muscle–sensitive therapeutic target for effective vascular repair. Arterioscler. Thromb. Vasc. Biol. 33, 2336–2344 (2013).
- Long CW, Levitzki A, Koshland D Jr. The subunit structure and subunit interactions of cytidine triphosphate synthetase. J. Biol. Chem. 245, 80–87 (1970).
- Torella D, Gasparri C, Ellison GM et al. Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85αPI3K. Am. J. Physiol. Heart Circ. Physiol. 297, H2015–H2025 (2009).
- Yoon JW, Cho BJ, Park HS et al. Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats. Int J. Cardiol. 167(1), 126–133 (2012).
- Hamesch K, Subramanian P, Li X et al. The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation. Thromb. Haemost. 107, 356 (2012).
- Iaconetti C, Polimeni A, Sorrentino S et al. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury. Basic Res. Cardiol. 107, 1–14 (2012).
- Khambata RS, Panayiotou CM, Hobbs AJ. Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide. Br. J. Pharmacol. 164, 584–597 (2011).
- Tsukie N, Nakano K, Matoba T et al. Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model. J. Atheroscler. Thromb. 20(1), 32–45 (2012).
- Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343–353 (2004).
- Kawabe-Yako R, Masaaki I, Masuo O, Asahara T, Itakura T. Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model. PLoS ONE 6, e24646 (2011).
- Giordano A, Romano S, Monaco M et al. Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 302, H135–H142 (2012).
- Tersteeg C, Roest M, Mak-Nienhuis EM et al. A fibronectin-fibrinogen-tropoelastin coating reduces smooth muscle cell growth but improves endothelial cell function. J. Cell. Mol. Med. 16, 2117–2126 (2012).